Volume : 11, Issue : 01, January – 2024
Title:
OVERVIEW OF NANOCARRIERS AS AN ANTI-CANCER AND TREATMENT
Authors :
Darshana V. Khillari , Saurabh S. Swami, Vaishnavi S. Mukhmale, Vinayak A. Katekar, Dr Swati P. Deshmukh
Abstract :
Nanotechnology has been laboriously integrated as medicine carriers over the last many times to treat colorful cancers. The main chain in the clinical operation of cancer is the development of multidrug resistance against chemotherapeutic agents. To overcome the limitations of chemotherapy, the experimenters have been developing technological advances for significant progress in the oncotherapy by enabling the delivery of chemotherapeutic agents at increased medicine content situations to the targeted spots. Several nano- medicine delivery systems designed for excrescence- targeting are estimated in preclinical and clinical trials and showed promising issues in cancerous excrescences’ clinical operation. This review describes nanocarrier’s significance in managing different types of cancers and emphasizing nanocarriers for medicine delivery and cancer nanotherapeutics. It also highlights the recent advances in nanocarriers- grounded delivery systems, including polymeric nanocarriers, micelles, nanotubes, dendrimers, glamorous nanoparticles, solid lipid nanoparticles, and amount blotches(QDs). The nanocarrier- grounded mixes are discussed in terms of their structure, characteristics, and therapeutic applications in oncology. To conclude, the challenges and future exploration opportunities of nanocarriers in chemotherapeutics are also presented. Cancer is a complicated disease for which finding a cure presents challenges. In recent decades, new ways to treat cancer are being sought; one being nanomedicine, which manipulates nanoparticles to target a cancer and release drugs directly to the cancer cells. A number of cancer treatments based on nanomedicine are under way and mostly are in preclinical trials owing to challenges in administration, safety, and effectiveness. One alternative method for drug delivery is the use of photovoltaic nanoparticles, which has the potential to deliver drugs via light activation. The concepts are based on standard photovoltaic cell that holds opposite charges on its surfaces and releases drugs when charge intensity or polarity changes upon photo-stimulation such as from a laser source or sunlight. This review will cover some recent progress in cancer treatment using nanoparticles, including photovoltaic nanoparticles.
Keywords: nanomaterials, anticancer agents, recent advances,multidrug resistance, chemotherapy
Cite This Article:
Please cite this article in press Darshana V. Khillari et al., Overview Of Nanocarriers As An Anti-Cancer And Treatment, Indo Am. J. P. Sci, 2024; 11 (01).
Number of Downloads : 10
References:
1.Ali I, Nadeem Lone M, Al-Othman Z, Al-Warthan A, Sanagi SM. Heterocyclic scaffolds: centrality in anticancer drug development. Curr Drug Targets.2015;16(7):711–734. Doi: 10.2174/1389450116666150309115922
2. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007;10(2):75–83.
3. García-Aranda M, Immunotherapy: RM. A challenge of breast cancer treatment. Cancers. 2019;11(12):1822.
4. Arruebo M, Vilaboa N, Sáez-Gutierrez B, et al. Assessment of the evolution of cancer treatment therapies. Cancers. 2011;3(3):3279–3330.
5. Aslam MS, Naveed S, Ahmed A, Abbas Z, Gull I, Athar MA. Side effects of chemotherapy in cancer patients and evaluation of patients opinion about starvation based differential chemotherapy. J Cancer Ther. 2014;2014.ncer treatment therapies. Cancers. 2011;3(3):3279–3330.
6. Rodgers GM, Becker PS, Blinder M, et al. Cancer-and chemotherapy-induced anemia. J Nat ComprehensCancer Network. 2012;10(5):628–653.
7. Gharpure KM, Wu SY, Li C, Lopez-Berestein G, Sood AK. Nanotechnology: future of oncotherapy. Clin Cancer Res. 2015;21(14):3121–3130.
8. Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA. Nanotechnology-based approaches in anticancer research. Int J Nanomedicine. 2012;7:4391.
9. Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16(1):71.
10. Wolfram J, Zhu M, Yang Y, et al. Safety of nanoparticles in medicine. Curr Drug Targets. 2015;16(14):1671–1681.
11. Stevanovic M, Uskokovic D. Poly (lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins. Curr Nanosci. 2009;5(1):1–14.
12. Wolfram J, Zhu M, Yang Y, et al. Safety of nanoparticles in medicine. Curr Drug Targets. 2015;16(14):1671–1681.
13. Rizvi SA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. 2018;26(1):64–70.
14. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005;23(1):1–25.
15.Gleich B, Weizenecker J. Tomographic imaging using the nonlinear response of magnetic particles. Nature. 2005;435(7046):1214–1217
16. Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res. 2006;23(7):1417–1450.
17. Bangham A. Liposomes: the Babraham connection. Chem Phys Lipids. 1993;64(1–3):275–285.
18. Propper D.J., Balkwill F.R. Harnessing cytokines and chemokines for cancer therapy. Nat. Rev. Clin. Oncol. 2022;19:237–253. Doi: 10.1038/s41571-021-00588-9.
19. Winkle M., El-Daly S.M., Fabbri M., Calin G.A. Noncoding RNA therapeutics—Challenges and potential solutions. Nat. Rev. Drug Discov. 2021;20:629–651. Doi: 10.1038/s41573-021-00219-z.
20. Abd-Aziz N., Poh C.L. Development of oncolytic viruses for cancer therapy. Transl. Res. 2021;237:98–123. Doi: 10.1016/j.trsl.2021.04.008.
21.Malik D., Mahendiratta S., Kaur H., Medhi B. Futuristic approach to cancer treatment. Gene. 2021;805:145906. Doi: 10.1016/j.gene.2021.145906.
22.Naidoo D.B., Chuturgoon A.A. Nanobodies Enhancing Cancer Visualization, Diagnosis and Therapeutics. Int. J. Mol. Sci. 2021;22:9778. Doi: 10.3390/ijms22189778.
23.Sindhwani S., Chan W.C.W. Nanotechnology for modern medicine: Next step towards clinical translation. J. Intern. Med. 2021;290:486–498. Doi: 10.1111/joim.13254.
24.Salata O. Applications of nanoparticles in biology and medicine. J. Nanobiotechnol. 2004;2:3. Doi: 10.1186/1477-3155-2-3.
25.Hegde P.S., Chen D.S. Top 10 Challenges in Cancer Immunotherapy. Immunity. 2020;52:17–35. Doi: 10.1016/j.immuni.2019.12.011.